Ionis Pharmaceuticals Impact Investors
Every moment matters in the discovery, development & delivery of life transforming genetic medicines. We are transforming the standard of care & pioneering new markets.
Estimated Revenue:
$100M to $500M
Funding Status:
IPO
Industry:
Innovation, Technology, and Research
Investors Number:
4
Last Funding Date:
2021-04-08
Acquisitions Number:
Made Acquisitions
Technology:
Biotechnology, Medical, Pharmaceutical
Founded Date:
1989-01-01
Headquarters:
Carlsbad, California
Total Funding:
751250000.0
Last Funding Type:
Post-IPO Debt
Employee Number:
251-500